High-resolution Proteomic Analysis of Medulloblastoma Clinical Samples Identifies Therapy Resistant Subgroups and MYC Immunohistochemistry As a Powerful Outcome Predictor.
Neuro-oncology(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined